Experience the Quality With Free ADC Exam Questions That Helps Candidates Pass

Counselors must practice within their competence. If lacking skills, they should refer or seek supervision/training before providing care. Accepting anyway (Option B) or pretending (Option C) risks harm. Client choice (Option D) does not override professional duty. This ensures ethical and effective treatment.

Naltrexone blocks opioid receptors, reducing the rewarding effects of alcohol and opioids. It is available orally or as a long-acting injectable (Vivitrol). Methadone (Option B) is a full agonist. Buprenorphine (Option C) is a partial agonist. Disulfiram (Option D) creates aversive reactions with alcohol but is not an antagonist. Naltrexone is evidence-based for relapse prevention, especially when combined with psychosocial counseling and monitoring.

Treating multiple family members raises concerns about dual relationships, confidentiality, and divided loyalties. Counselors must clarify boundaries, obtain informed consent, and consider referral if objectivity is compromised. Insurance issues (Option B) may arise but are secondary. Confrontation (Option C) is unrelated here. Supervision (Option D) supports practice but is not the core ethical issue. Managing dual relationships protects fairness and client trust.

The Penn Craving Scale measures intensity, frequency, and duration of cravings, key relapse predictors. The ASI (Option A) covers psychiatric history but not cravings specifically. COWS (Option C) assesses opioid withdrawal, and CIWA-Ar (Option D) measures alcohol withdrawal. Craving assessment supports relapse-prevention planning and monitoring treatment effectiveness.

Stepped care matches clients to the least restrictive, most effective setting (e.g., outpatient vs. residential), increasing intensity only as needed. Harm reduction (Option B) emphasizes safer use. Abstinence-only (Option C) excludes moderation goals. Crisis intervention (Option D) addresses acute issues, not ongoing placement. Stepped care balances autonomy, cost-effectiveness, and clinical effectiveness.